Post-transplant immunosuppressive regimens are essential for preventing organ rejection, but they can also put patients at risk of opportunistic infections.
Amongst others Cytomegalovirus (CMV), Epstein-Barr Virus (EBV), and BK Virus (BKV) are associated with significant morbidity and mortality in transplant recipients.1
These infections can be introduced through the donor organ or re-activated after the operation. By regularly monitoring viral load, care teams can identify possible infections early and better decide on an appropriate management plan.